Treatment of exudative age-related macular degeneration with intravitreal ranibizumab in clinical practice: a 3-year follow-up [PDF]
, 2013 PURPOSE: To evaluate the 36-month efficacy of intravitreal ranibizumab injections for choroidal neovascularization secondary to age-related macular degeneration (AMD) in real world clinical practice.
Faria de Abreu, JR +6 more
core +1 more source
Al-Azhar Assiut Medical Journal, 2019 Background Diabetic macular edema (DME) is a common cause of blindness and visual impairment in diabetic patients, which can affect the quality of life.
Abd El-Magid M Tag El-Din
doaj +1 more source
Treatment of Retinitis Pigmentosa-Associated Cystoid Macular Oedema Using Intravitreal Aflibercept (Eylea) despite Minimal Response to Ranibizumab (Lucentis): A Case Report. [PDF]
, 2016 BACKGROUND: We present an interesting case of bilateral retinitis pigmentosa (RP)-associated cystoid macular oedema that responded on two separate occasions to intravitreal injections of aflibercept, despite previously demonstrating only minimal response
Gurbaxani, A, Michaelides, M, Strong, SA
core +3 more sources
Intravitreal ranibizumab and bevacizumab in combination with full-fluence verteporfin therapy and dexamethasone for exudative age-related macular degeneration. [PDF]
, 2011 PURPOSE: To evaluate the efficacy and safety of triple therapy with intravitreal anti-vascular-endothelial-growth-factor (VEGF) antibody, dexamethasone and verteporfin photodynamic therapy (PDT) for exudative age-related macular degeneration (AMD ...
Adenis JP +4 more
core +1 more source
Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys.
PLoS ONE, 2014 PurposeIt is known that endothelial cells in the kidney are also strongly VEGF-dependent. Whether intravitreal drugs can be detected within the glomeruli or affect VEGF in glomerular podocytes is not known.
Alexander Tschulakow +5 more
doaj +1 more source
The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema [PDF]
, 2016 Aims: To describe baseline characteristics and visual outcome for eyes treated with ranibizumab for diabetic macular oedema (DMO) from a multicentre database.
Akerele, T. +25 more
core +1 more source
Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab
Clinical Ophthalmology, 2011 Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C, Stem M, Comer GM
doaj
Mechanisms of ranibizumab as an anti-scarring agent in trabeculectomy / Siti Munirah Md Noh [PDF]
, 2018 Trabeculectomy is the gold standard procedure performed in glaucoma when topical medication and laser intervention fail to maintain the ideal intraocular pressure (IOP) of patient’s eye. However, excessive accumulation of extracellular matrix components (
Md Noh, Siti Munirah
core
Multi-line Adaptive Perimetry (MAP): A New Procedure for Quantifying Visual Field Integrity for Rapid Assessment of Macular Diseases. [PDF]
, 2018 PurposeIn order to monitor visual defects associated with macular degeneration (MD), we present a new psychophysical assessment called multiline adaptive perimetry (MAP) that measures visual field integrity by simultaneously estimating regions associated
Biles, Mandy K +5 more
core +1 more source
Hosszú távú intravitrealis ranibizumabkezelés exsudativ időskori maculadegenerációban [PDF]
, 2013 Bevezetés: Az exsudativ időskori maculadegeneráció kezelésére alkalmazott intravitrealis ranibizumabinjekcióval szerzett eddigi tapasztalatok kedvezőek.
Borbándy, Ágnes +7 more
core +1 more source